Emel Bülbül Başkan

1.7k total citations · 1 hit paper
72 papers, 865 citations indexed

About

Emel Bülbül Başkan is a scholar working on Dermatology, Rheumatology and Pathology and Forensic Medicine. According to data from OpenAlex, Emel Bülbül Başkan has authored 72 papers receiving a total of 865 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Dermatology, 20 papers in Rheumatology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Emel Bülbül Başkan's work include Autoimmune Bullous Skin Diseases (12 papers), Urticaria and Related Conditions (12 papers) and Dermatology and Skin Diseases (11 papers). Emel Bülbül Başkan is often cited by papers focused on Autoimmune Bullous Skin Diseases (12 papers), Urticaria and Related Conditions (12 papers) and Dermatology and Skin Diseases (11 papers). Emel Bülbül Başkan collaborates with scholars based in Türkiye, United States and Germany. Emel Bülbül Başkan's co-authors include Şükran Tunalı, Hayriye Sarıcaoğlu, Carsten Bindslev‐Jensen, Panayiotis Georgiou, Sheldon L. Spector, Jean‐Jacques Grob, Marcus Maurer, Karin Rosén, Oral Alpan and Mary S. Bradley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Investigative Dermatology and Journal of the American Academy of Dermatology.

In The Last Decade

Emel Bülbül Başkan

60 papers receiving 843 citations

Hit Papers

Efficacy and Safety of Omalizumab in Patients with Chroni... 2014 2026 2018 2022 2014 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study
    2014 307 citations Emel Bülbül Başkan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emel Bülbül Başkan Türkiye 15 467 320 248 245 158 72 865
Farzan Solimani Germany 16 304 0.7× 441 1.4× 293 1.2× 185 0.8× 154 1.0× 40 881
Chika Ohata Japan 18 429 0.9× 529 1.7× 236 1.0× 350 1.4× 172 1.1× 75 924
Ya‐Gang Zuo China 13 174 0.4× 209 0.7× 201 0.8× 131 0.5× 90 0.6× 68 543
Conleth A. Egan United States 19 445 1.0× 530 1.7× 165 0.7× 297 1.2× 88 0.6× 51 958
Barbara Giomi Italy 15 498 1.1× 323 1.0× 165 0.7× 226 0.9× 224 1.4× 36 740
María A. Barnadas Spain 18 276 0.6× 383 1.2× 220 0.9× 190 0.8× 62 0.4× 62 869
Pierre Y. Venencie France 18 371 0.8× 248 0.8× 462 1.9× 124 0.5× 108 0.7× 43 1.2k
Takaya Fukumoto Japan 14 256 0.5× 160 0.5× 161 0.6× 53 0.2× 126 0.8× 57 596
Assi Levi Israel 15 150 0.3× 130 0.4× 373 1.5× 96 0.4× 178 1.1× 73 882
Rafael Herrera‐Esparza Mexico 15 321 0.7× 240 0.8× 49 0.2× 118 0.5× 255 1.6× 72 717

Countries citing papers authored by Emel Bülbül Başkan

Since Specialization
Citations

This map shows the geographic impact of Emel Bülbül Başkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emel Bülbül Başkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emel Bülbül Başkan more than expected).

Fields of papers citing papers by Emel Bülbül Başkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emel Bülbül Başkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emel Bülbül Başkan. The network helps show where Emel Bülbül Başkan may publish in the future.

Co-authorship network of co-authors of Emel Bülbül Başkan

This figure shows the co-authorship network connecting the top 25 collaborators of Emel Bülbül Başkan. A scholar is included among the top collaborators of Emel Bülbül Başkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emel Bülbül Başkan. Emel Bülbül Başkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karpat, Fatih, et al.. (2024). Investigation of infectious droplet dispersion in a hospital examination room cooled by split-type air conditioner. Journal of Environmental Health Science and Engineering. 22(2). 471–482.
2.
Kocatürk, Emek, Emel Bülbül Başkan, Mustafa Özdemir, et al.. (2022). Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?. Anais Brasileiros de Dermatologia. 97(5). 592–600. 12 indexed citations
3.
Başkan, Emel Bülbül, et al.. (2022). Factors Related to Omalizumab Drug Survival and Treatment Responses in Chronic Urticaria. International Archives of Allergy and Immunology. 183(11). 1198–1208. 2 indexed citations
4.
Başkan, Emel Bülbül, et al.. (2022). Birt-Hogg-Dubé Syndrome: Diagnostic Journey of Three Cases from Skin to Gene. Annals of Dermatology. 34(1). 66–66. 4 indexed citations
5.
Koca, Rafet, Emek Kocatürk, Ekin Şavk, et al.. (2021). Patch Test Results to European Baseline Series in Turkey: A Prospective and Multicenter Study. Dermatitis. 32(6). 397–405. 4 indexed citations
6.
Başkan, Emel Bülbül, Deniz Sığırlı, Ferah Budak, et al.. (2020). Predictors of drug survival of biologic therapies in psoriasis patients. Journal of Dermatological Treatment. 33(1). 437–442. 11 indexed citations
7.
Salman, Andaç, Sibel Alper, Nilgün Atakan, et al.. (2020). Recommendations on the use of systemic treatments for urticaria and atopic dermatitis during the COVID-19 pandemic: Statement of Dermatoallergy Working Group of the Turkish Society of Dermatology. Bursa Uludag University - AVESIS. 54(2). 71–75. 2 indexed citations
8.
Başkan, Emel Bülbül & Aslı Akın Belli. (2018). Evaluation of long-term efficacy, safety, and effect on life quality of pulsed dye laser in rosacea patients. Journal of Cosmetic and Laser Therapy. 21(4). 185–189. 10 indexed citations
9.
Sarıcaoğlu, Hayriye, et al.. (2018). Cyclosporine-A for severe childhood atopic dermatitis: clinical experience on efficacy and safety profile. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(5). 933–938. 8 indexed citations
10.
Akyol, Melih, Sibel Alper, Nilgün Atakan, et al.. (2016). Türkiye psoriasis tedavi kılavuzu-2016. Istanbul Science University (Istanbul Bilim University). 50. 2–3. 1 indexed citations
11.
Kocatürk, Emek, Şebnem Aktan, Nilgün Atakan, et al.. (2016). The Turkish Guideline for the Diagnosis and Management of Urticaria-2016. TURKDERM. 50(3). 82–98. 27 indexed citations
12.
Dalkılıç, Ediz, Emel Bülbül Başkan, Mustafa Güllülü, et al.. (2012). Tumor necrosis factor-alpha antagonist therapy-induced psoriasis in Turkey: analysis of 514 patients. Modern Rheumatology. 22(5). 738–742. 9 indexed citations
13.
Sarıcaoğlu, Hayriye, Mehmet Birhan Yılmaz, Mutlu Karkucak, et al.. (2011). Investigation of ABCB1 gene polymorphism with colchicine response in Behçet’s disease. Genetics and Molecular Research. 10(1). 1–6. 15 indexed citations
14.
Sarıcaoğlu, Hayriye, et al.. (2011). Pediyatrik Morfea (Lokalize Skleroderma) 14 Olguya Ait Epidemiyolojik Klinik ve Laboratuvar Bulguları. TURKDERM. 45(3). 132–136. 1 indexed citations
15.
Başkan, Emel Bülbül, et al.. (2010). Patch Test Results with Standard and Cosmetic Series in Patients with Suspected Cosmetic-Induced Contact Dermatitis. TURKDERM. 44(4). 193–199.
16.
Başkan, Emel Bülbül. (2010). Allerjik Kontakt Dermatit. 3(1). 6–22. 1 indexed citations
17.
Başkan, Emel Bülbül, Emel Yılmaz, Hayriye Sarıcaoğlu, et al.. (2007). Detection of parvovirus B19 DNA in the lesional skin of patients with Behçet's disease. Clinical and Experimental Dermatology. 32(2). 186–190. 36 indexed citations
18.
Başkan, Emel Bülbül, et al.. (2006). A case of epidermodysplasia verruciformis associated with squamous cell carcinoma and Bowen's disease: A therapeutic challenge. Journal of Dermatological Treatment. 17(3). 179–183. 13 indexed citations
19.
Başkan, Emel Bülbül, et al.. (2005). Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. International Journal of Dermatology. 44(12). 993–995. 21 indexed citations
20.
Başkan, Emel Bülbül, et al.. (2004). Lack of correlation between Helicobacter pylori infection and autologous serum skin test in chronic idiopathic urticaria. International Journal of Dermatology. 0(0). 2128163567–2128163567. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Farzan Solimani Breakdown of academic impact, for papers by Chika Ohata Breakdown of academic impact, for papers by Ya‐Gang Zuo Breakdown of academic impact, for papers by Conleth A. Egan Breakdown of academic impact, for papers by Barbara Giomi Breakdown of academic impact, for papers by María A. Barnadas Breakdown of academic impact, for papers by Pierre Y. Venencie Breakdown of academic impact, for papers by Takaya Fukumoto Breakdown of academic impact, for papers by Assi Levi Breakdown of academic impact, for papers by Rafael Herrera‐Esparza
Rankless by CCL
2026